Cleared Traditional

K123085 - FUTURO (TM) TRAVEL KNEE-HIGHS

Also marketed or referenced as:
FUTURO (TM) TRAVEL SOCKS FUTURO (TM) TRAVEL STOCKINGS FUTURO (TM) TRAVEL PANTYHOSE

K123085 is the FDA 510(k) clearance for FUTURO (TM) TRAVEL KNEE-HIGHS by 3M Company. It is a Class 2 General Hospital device (product code DWL) cleared through the Traditional 510(k) pathway after a 80-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2012
Decision
80d
Days
Class 2
Risk

K123085 is an FDA 510(k) clearance for the FUTURO (TM) TRAVEL KNEE-HIGHS. Classified as Stocking, Medical Support (to Prevent Pooling Of Blood In Legs) (product code DWL), Class II - Special Controls.

Submitted by 3M Company (Saint Paul, US). The FDA issued a Cleared decision on December 20, 2012 after a review of 80 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5780 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all 3M Company devices

Submission Details

510(k) Number K123085 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 01, 2012
Decision Date December 20, 2012
Days to Decision 80 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
49d faster than avg
Panel avg: 129d · This submission: 80d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DWL Stocking, Medical Support (to Prevent Pooling Of Blood In Legs)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5780
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - DWL Stocking, Medical Support (to Prevent Pooling Of Blood In Legs)

Devices cleared under the same product code (DWL) and FDA review panel - the closest regulatory comparables to K123085.
MEDLINE ANTI-EMBOLISM STOCKING
K141127 · Medline Industries, Inc. · Aug 2014
CURAD COMPRESSION HOSIERY
K112769 · Medline Industries, Inc. · Mar 2012
KENDALL HOME RX THERAPEUTIC STOCKING
K925417 · Kendall Healthcare Products Co. Div.Of Tyco Health · Jun 1993
SCD THERAPEUTIC STOCKING SYSTEM
K902497 · Kendall Healthcare Products Co. Div.Of Tyco Health · Aug 1990
ENHANCE SUPPORT HOSE
K873280 · Kimberly-Clark Corp. · Oct 1987
A.V.R. KNEE LENGTH THERAPEUTIC STOCK-
K832609 · The Kendal Co. · Sep 1983